InvestorsHub Logo
Followers 22
Posts 1490
Boards Moderated 0
Alias Born 07/29/2013

Re: None

Tuesday, 03/26/2019 12:20:01 AM

Tuesday, March 26, 2019 12:20:01 AM

Post# of 82961
Here's some good news!
https://energyandresourcesdigest.com/cannabis-companies-ranked-debt-to-equity-ratio/

4) CV Sciences (OTC: CVSI) reported earlier this month that 2018 revenue increased 133% to $48.2 million. Net income was a record $10 million, or $0.09 per share.

A reader asked about CV Sciences in the comments section. I’ve been covering the company for over a year, and I think it’s in a very strong position. Shares are moving higher along with Curaleaf and the rise of CBD.

Revenue is projected to jump 68% this year to $81.1 million. It’s also appeared many times in Making the Grade for all the right reasons.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CVSI News